Abstract:Abstract Funding Acknowledgements Type of funding sources: None. Cardiovascular disease (CVD) is the leading cause of death in most countries [1]. Risk factors known to predispose to the development of CVD include increasing age, male gender, diabetes mellitus, high blood cholesterol, tobacco smoking, high blood pressure (hypertension), obesity, physical inactivity, and family history [2]. Elevated plasma homocysteine is also an independent risk factor for CVD [2,3]. The mechanism by which elevated homocysteine contributes to CVD risk is not well understood, but it is well-established that dietary folate and vitamin B supplementation can reduce serum homocysteine levels by facilitating remethylation of homocysteine to methionine [4]. DNA methylation can modulate gene expression in response to exposure to various substances, such as nutrients, smoking, and environmental chemicals.Variation in healthy aging and lifespan is ascribed more to various non-genetic factors than to inherited genetic determinants, and a major goal in aging research is to reveal the epigenetic basis of aging. The remethylation cycle is essential for the systemic methyl donor supply, which is used for important biological processes, such as cytosine-5 methylation of genomic DNA, an epigenetic modification that plays an important role in maintaining genomic stability, chromatin structure, and in controlling transcriptional capacity [2,4]. Methodology/Principal Findings In this prospective study, we examined both gender patients, aged 40-50 years. Relationship between prevalence of Cardiometabolic risk factors (metabolic syndrome, oxidative stress and arterial hypertension) or its predisposing conditions (hypertrigliceridemia, dislipedimia, inusline resistance, D vitamin hipovitaminosis)) and DNA hydroximethylation was investigated. Hydroxymethylation measurement was done using a gold standard technique (liquid chromatography + mass spectrometry), the biological age equivalent was calculated by LC-MS in laboratories Reunis, to verify the potential value of DNA methylation as a CVD biomarker. Results Generally, 296 both gender patients were analyzed regarding metabolic syndrome and oxidative stress, age group 40-50 years (Me=47,1). MethylAge (DNA-hydroxymethylation) in analyzed group has average age 40,1 years old. DNA Hydroxymethylation is higher in those individuals, who has increased waist circumference, as well as, statistically significant correlation was observed between MethylAge waist circumference, metabolic syndrome and hypertriglyceridemia (p<0,05). Conclusion The evidence that the age-related changes in DNA methylation play a role in aging comes from studies of anti-aging interventions (e.g., caloric restriction, iron deficiency, dyslipidemia). Our data showed a link between premature biological ageing and waist circumference, hypertrigliceridimia. Hydroxymethylation of DNA is a good epigenetic marker for aging and risk assessment, especially in alliance with AGEs and oxidative stress research.

Associations of Plasma Folate and Vitamin B6 with Blood DNA Methylation Age: an Analysis of One-Carbon Metabolites in the VA Normative Aging Study.

The effects of long-term daily folic acid and vitamin B12 supplementation on genome-wide DNA methylation in elderly subjects

Associations Between Long-Term Exposure to PM2.5 Component Species and Blood DNA Methylation Age in the Elderly: the VA Normative Aging Study

Modulation of DNA methylation by one-carbon metabolism: a milestone for healthy aging

DNA methylation as a biomarker for cardiometabolic disease risk

Genome-wide association studies identify 137 loci for DNA methylation biomarkers of ageing

Editor's Highlight: Modifying Role of Endothelial Function Gene Variants on the Association of Long-Term PM2.5 Exposure with Blood DNA Methylation Age: the VA Normative Aging Study.

DNA methylation age of blood predicts all-cause mortality in later life

Smoking-Related DNA Methylation is Associated with DNA Methylation Phenotypic Age Acceleration: the Veterans Affairs Normative Aging Study

Weight management intervention identifies association of decreased DNA methylation age with improved functional age measures in older adults with obesity

Abstract P271: Dna Methylation Measures of Aging in Midlife Are Associated with Frailty Components in African American and European American Older Adults: the Atherosclerosis Risk in Communities (ARIC) Study

Genome-wide association studies identify 137 genetic loci for DNA methylation biomarkers of aging

DNA methylation correlates of chronological age in diverse human tissue types

Dietary factors and DNA methylation-based markers of ageing in 5310 middle-aged and older Australian adults

DNA Hydroxymethylation Age of Human Blood Determined by Capillary Hydrophilic-Interaction Liquid Chromatography/mass Spectrometry

One-carbon metabolites and telomere length in a prospective and randomized study of B- and/or D-vitamin supplementation

Individual species and cumulative mixture relationships of 24-hour urine metal concentrations with DNA methylation age variables in older men

DNA Methylation-Based Biomarkers of Age Acceleration and All-Cause Death, Myocardial Infarction, Stroke, and Cancer in Two Cohorts: the NAS, and KORA F4

Quantification of the pace of biological aging in humans through a blood test: The DunedinPoAm DNA methylation algorithm

Impacts of the Mitochondrial Genome on the Relationship of Long-Term Ambient Fine Particle Exposure with Blood DNA Methylation Age.

Association of dietary folate and vitamin B-12 intake with genome-wide DNA methylation in blood: a large-scale epigenome-wide association analysis in 5841 individuals